Meritech Capital Associates V L.L.C. 10x Genomics, Inc. Transaction History

Meritech Capital Associates V L.L.C.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$34.32 - $57.55 $8.8 Million - $14.7 Million	-256,266 Reduced 34.15%	494,236 $27.7 Million
Q1 2023 May 15, 2023	SELL	$35.33 - $55.79 $11 Million - $17.4 Million	-311,180 Reduced 29.31%	750,502 $41.9 Million
Q2 2022 Aug 15, 2022	SELL	$36.95 - $82.41 $10.1 Million - $22.6 Million	-274,571 Reduced 20.55%	1,061,682 $48 Million
Q1 2022 May 16, 2022	SELL	$55.7 - $145.79 $15.3 Million - $40 Million	-274,571 Reduced 17.05%	1,336,253 $102 Million
Q4 2021 Feb 14, 2022	SELL	$135.05 - $182.59 $24.7 Million - $33.4 Million	-183,047 Reduced 10.2%	1,610,824 $240 Million
Q2 2021 Aug 16, 2021	SELL	$134.22 - $202.37 $44.2 Million - $66.7 Million	-329,485 Reduced 15.52%	1,793,871 $351 Million
Q1 2021 May 17, 2021	SELL	$140.25 - $196.86 $64.2 Million - $90.1 Million	-457,619 Reduced 17.73%	2,123,356 $384 Million
Q4 2020 Feb 16, 2021	BUY	$126.47 - $163.7 $326 Million - $423 Million	2,580,975 New	2,580,975 $365 Million

291

94.7M

263K

85.1K

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.5B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

Get notified when there are updates to the investment portfolio of Meritech Capital Associates V L.L.C., based on Form 13F filings with the SEC.

Stay updated on Meritech Capital Associates V L.L.C. with notifications on news.